Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation

M. S. Kies, Leo I Gordon, S. T. Rosen, O. Kucuk, H. M. Vriesendorp

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

A major obstacle to succesful autologous bone marrow transplantation in breast cancer is infiltration of the marrow by malignant cells. We layered bone marrow samples from seven breast cancer patients on a discontinuous bovine albumin gradient, then assessed hematopoietic potential (colony-forming units-culture [CFU(c)] and clonogenic tumor cells [TCFU(c)] by standard techniques. We found that 78% of CFU(c) concentrated in fraction 3 of the gradient, which contained 10% of the total nucleated cell population. TCFU(c) were distributed across the gradient with 14% of colonies identified in this marrow fraction. We applied these techniques to two patients with metastatic breast cancer who were treated with high-dose mitomycin-C, doxorubicin and cyclophosphamide before receiving 1.9 x 109 and 1.2 x 109 total cells, respectively, from CFU(c)-rich fraction 3. We observed tumor colony growth in three patients only in separated marrow fractions, suggesting that colony growth may be a function of the cell composition after fractionation or that growth factors may be separable. Ninety percent of clonogenic breast cancer cells can be separated from hematopoietic cells by discontinuous density gradient fractionation, a technique that is applicable to the large volumes necessary in bone marrow transplantation and that may be an important initial step in marrow purging for autologous transplantation.

Original languageEnglish (US)
Pages (from-to)190-194
Number of pages5
JournalExperimental Hematology
Volume16
Issue number3
StatePublished - Jan 1 1988

ASJC Scopus subject areas

  • Molecular Biology
  • Hematology
  • Genetics
  • Cell Biology
  • Cancer Research

Fingerprint Dive into the research topics of 'Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation'. Together they form a unique fingerprint.

Cite this